A detailed history of Jpmorgan Chase & CO transactions in Treace Medical Concepts, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 400,546 shares of TMCI stock, worth $2.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
400,546
Previous 377,872 6.0%
Holding current value
$2.17 Million
Previous $4.93 Million 45.99%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$4.17 - $12.62 $94,550 - $286,145
22,674 Added 6.0%
400,546 $2.66 Million
Q1 2024

May 10, 2024

BUY
$11.48 - $15.86 $13,994 - $19,333
1,219 Added 0.32%
377,872 $4.93 Million
Q4 2023

Feb 12, 2024

BUY
$6.03 - $12.88 $169,352 - $361,734
28,085 Added 8.06%
376,653 $4.8 Million
Q3 2023

Nov 14, 2023

SELL
$12.16 - $24.87 $371,427 - $759,654
-30,545 Reduced 8.06%
348,568 $4.57 Million
Q2 2023

Aug 11, 2023

BUY
$23.91 - $27.81 $2.34 Million - $2.72 Million
97,910 Added 34.82%
379,113 $9.7 Million
Q1 2023

May 18, 2023

BUY
$20.23 - $26.22 $914,476 - $1.19 Million
45,204 Added 19.15%
281,203 $7.08 Million
Q1 2023

May 11, 2023

BUY
$20.23 - $26.22 $42,078 - $54,537
2,080 Added 0.89%
235,999 $5.94 Million
Q4 2022

Feb 13, 2023

BUY
$20.54 - $24.67 $94,032 - $112,939
4,578 Added 2.0%
233,919 $5.38 Million
Q3 2022

Nov 14, 2022

BUY
$14.71 - $24.18 $51,352 - $84,412
3,491 Added 1.55%
229,341 $5.06 Million
Q2 2022

Aug 11, 2022

SELL
$12.93 - $20.29 $120,546 - $189,163
-9,323 Reduced 3.96%
225,850 $3.24 Million
Q1 2022

May 11, 2022

SELL
$16.73 - $21.58 $474,027 - $611,447
-28,334 Reduced 10.75%
235,173 $4.45 Million
Q4 2021

Feb 10, 2022

BUY
$15.48 - $26.52 $2.73 Million - $4.68 Million
176,598 Added 203.2%
263,507 $4.91 Million
Q3 2021

Nov 12, 2021

BUY
$24.15 - $30.5 $2.1 Million - $2.65 Million
86,909 New
86,909 $2.34 Million

Others Institutions Holding TMCI

About TREACE MEDICAL CONCEPTS, INC.


  • Ticker TMCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 55,403,300
  • Market Cap $301M
  • Description
  • Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical impro...
More about TMCI
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.